Development of comprehensive disease assessment in systemic vasculitis

Research output: Contribution to journalArticle

Standard

Development of comprehensive disease assessment in systemic vasculitis. / Flossmann, O; Bacon, Paul; de Groot, K; Jayne, DRW; Rasmussen, N; Seo, P; Westman, K; Luqmani, R.

In: Annals of the Rheumatic Diseases, Vol. 66, No. 3, 01.03.2007, p. 283-92.

Research output: Contribution to journalArticle

Harvard

Flossmann, O, Bacon, P, de Groot, K, Jayne, DRW, Rasmussen, N, Seo, P, Westman, K & Luqmani, R 2007, 'Development of comprehensive disease assessment in systemic vasculitis', Annals of the Rheumatic Diseases, vol. 66, no. 3, pp. 283-92. https://doi.org/10.1136/ard.2005.051078

APA

Flossmann, O., Bacon, P., de Groot, K., Jayne, DRW., Rasmussen, N., Seo, P., Westman, K., & Luqmani, R. (2007). Development of comprehensive disease assessment in systemic vasculitis. Annals of the Rheumatic Diseases, 66(3), 283-92. https://doi.org/10.1136/ard.2005.051078

Vancouver

Author

Flossmann, O ; Bacon, Paul ; de Groot, K ; Jayne, DRW ; Rasmussen, N ; Seo, P ; Westman, K ; Luqmani, R. / Development of comprehensive disease assessment in systemic vasculitis. In: Annals of the Rheumatic Diseases. 2007 ; Vol. 66, No. 3. pp. 283-92.

Bibtex

@article{1ae5515b88594ae1aa9a0d112abee7eb,
title = "Development of comprehensive disease assessment in systemic vasculitis",
abstract = "The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis requires documentation of disease activity, chronic irreversible damage and impairment of function.",
author = "O Flossmann and Paul Bacon and {de Groot}, K and DRW Jayne and N Rasmussen and P Seo and K Westman and R Luqmani",
year = "2007",
month = mar,
day = "1",
doi = "10.1136/ard.2005.051078",
language = "English",
volume = "66",
pages = "283--92",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "3",

}

RIS

TY - JOUR

T1 - Development of comprehensive disease assessment in systemic vasculitis

AU - Flossmann, O

AU - Bacon, Paul

AU - de Groot, K

AU - Jayne, DRW

AU - Rasmussen, N

AU - Seo, P

AU - Westman, K

AU - Luqmani, R

PY - 2007/3/1

Y1 - 2007/3/1

N2 - The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis requires documentation of disease activity, chronic irreversible damage and impairment of function.

AB - The systemic vasculitides are multisystem disorders with considerable mortality and morbidity and frequent relapses. In the absence of reliable serological markers, accurate clinical tools are required to assess disease activity and damage for treatment decisions, and for the performance of clinical trials. This article reviews and summarises the development and use of disease assessment tools for determining activity and damage in systemic vasculitis and reports ongoing initiatives for further development of disease assessment tools. A literature search was conducted using PubMed and reference lists for vasculitis, assessment, clinical trials, outcome and prognosis. The findings indicate that comprehensive disease assessment in vasculitis requires documentation of disease activity, chronic irreversible damage and impairment of function.

UR - http://www.scopus.com/inward/record.url?scp=41849144122&partnerID=8YFLogxK

U2 - 10.1136/ard.2005.051078

DO - 10.1136/ard.2005.051078

M3 - Article

C2 - 16728460

VL - 66

SP - 283

EP - 292

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 3

ER -